PITTSBURGH, Oct. 7, 2016 – Stanley Marks, M.D., a leading UPMC oncologist and advocate for cancer patients throughout the western Pennsylvania region, was honored by UPMC and his medical partners at Oncology Hematology Association (OHA) through the establishment of the Stanley M. Marks – OHA Endowed Chair in Hematology/Oncology Leadership.
Every one of his 48 partners at OHA, a UPMC-owned practice, financially committed to create this chair, which also was supported by UPMC, for a total of $2.2 million.
The permanent endowment will support the recruitment and retention of outstanding leaders in the University of Pittsburgh Division of Hematology/Oncology. It also will help to train professionals devoted to research and improved treatments for patients.
Dr. Marks has directed and overseen the continued growth and success of the UPMC CancerCenter, a partner with the University of Pittsburgh Cancer Institute and now one of the largest cancer care networks in the nation.
“None of this would have been possible without the support of my colleagues and UPMC,” said Dr. Marks. “This endowment will enable us to recruit a medical and scientific star, ultimately leading to better care for our patients.”
Added Barry Lembersky, M.D., “Through his decades-long leadership of OHA and the UPMC CancerCenter, Stan has made a significant impact on cancer care and research in our region and beyond. All of the physicians in OHA wish to honor his outstanding contributions and provide a legacy to benefit patients for generations to come.”
Dr. Marks serves as chairman of UPMC CancerCenter, chief of the Division of Hematology and Oncology at UPMC Shadyside, and as a clinical professor of medicine at the University of Pittsburgh School Of Medicine. He also has been named consistently as one of the “Top Physicians in Pittsburgh” and “Best Doctors of America” in hematology and medical oncology by Best Doctors®.